CAS: 2244614-14-8 - 1-[6-Ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-quinolinyl]-N-(tetrahydro-2H-pyran-4-yl)-4-piperidinamine
Formula:C25H32FN5O2
InChI:InChI=1S/C25H32FN5O2/c1-4-17-13-20-15(2)22(25-27-16(3)30-33-25)24(29-23(20)21(26)14-17)31-9-5-18(6-10-31)28-19-7-11-32-12-8-19/h13-14,18-19,28H,4-12H2,1-3H3
InChI key:InChIKey=CQOJHAJWCDJEAT-UHFFFAOYSA-N
SMILES:FC1=CC(=CC2=C1N=C(C(C3=NC(=NO3)C)=C2C)N4CCC(NC5CCOCC5)CC4)CC
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
BTRX-335140 REF: TM-T14835CAS: 2244614-14-8 | 98.45% | 105.00 €~2,612.00 € | Fri 31 May 24 | |
BTRX-335140 REF: 3D-UPD61414CAS: 2244614-14-8 | Min. 95% | To inquire | Fri 12 Jul 24 |
BTRX-335140
CAS:2244614-14-8
BTRX-335140 (CYM-53093) is a potent and selective, orally active κ opioid receptor (KOR) antagonist, has …
Formula:
C25H32FN5O2
Purity:
98.45%
Color and Shape:
Solid
Molecular weight:
453.55
Ref: TM-T14835
1mg | 105.00 € | |
2mg | 154.00 € | |
5mg | 248.00 € | |
10mg | 404.00 € | |
25mg | 835.00 € | |
50mg | 1,368.00 € | |
100mg | 1,867.00 € | |
200mg | 2,612.00 € | |
1ml*10 (DMSO) | 280.00 € |
Estimated delivery in United States, on Friday 31 May 2024
BTRX-335140
CAS:2244614-14-8
BTRX-335140 is a novel compound that has been shown to modulate the opioid receptor. It …
Formula:
C25H32FN5O2
Purity:
Min. 95%
Molecular weight:
453.6 g/mol
Ref: 3D-UPD61414
1mg | To inquire | |
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire |
Estimated delivery in United States, on Friday 12 Jul 2024